Clinical Trials Directory

Trials / Unknown

UnknownNCT00742040

Rapid Versus Prolonged Inpatient Up-Titration of Captopril

Rapid Versus Prolonged Inpatient Up-Titration of Captopril: A Randomized Clinical Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to establish a safe and effective method of up-titration of captopril for hospital inpatients.

Detailed description

Angiotensin converting enzyme inhibitors (ACEi) are one of the most frequently prescribed pediatric cardiac medication and overall their safety in children is widely accepted. Pediatric formulary recommendations for ACEi suggest starting with a low initial dose (0.1 mg/kg), to avoid hypotension, and up-titration for a maintenance dose. However, side ranges are quoted for maintenance doses and no guidance is given as to the best method of up-titration, The physician is left uncertain of the optimal dose and how best to achieve it. The ultimate goal of this study is to be in a position to provide physicians caring for children with heart disease information about how to safely up-titrate this widely used medication, and by doing so to improve dosing in the wider pediatric population.

Conditions

Interventions

TypeNameDescription
DRUGCaptoprilA rapid 3-day up-titration protocol
DRUGCaptoprilA slower 9-day up-titration protocol

Timeline

Start date
2008-08-01
Primary completion
2009-08-01
Completion
2009-12-01
First posted
2008-08-27
Last updated
2008-08-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00742040. Inclusion in this directory is not an endorsement.